Academic Journal
Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation
| العنوان: | Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation |
|---|---|
| المؤلفون: | Russo V., Silverio A., Scudiero F., D'andrea A., Attena E., Di Palma G., Parodi G., Caso V., Albani S., Galasso G., Imbalzano E., Golino P., Di Maio M. |
| المساهمون: | Russo, V., Silverio, A., Scudiero, F., D'Andrea, A., Attena, E., Di Palma, G., Parodi, G., Caso, V., Albani, S., Galasso, G., Imbalzano, E., Golino, P., Di Maio, M. |
| بيانات النشر: | MDPI |
| سنة النشر: | 2022 |
| المجموعة: | Università degli Studi di Messina: IRIS |
| مصطلحات موضوعية: | Atrial fibrillation, COVID-19, Mortality, Novel coronaviru, Outcome, SARS-CoV-2, Female, Human, Male, Prognosi, Retrospective Studie, Risk Factor |
| الوصف: | Background and objectives: Pre-existing atrial fibrillation (AF) is a frequent comorbidity in hospitalized patients with COVID-19; however, little is still known about its prognostic role in infected patients. The aim of our study was to evaluate whether the pre-existing AF as comorbidity would contribute to increase the risk for severe forms of COVID-19, worse prognosis, or even higher mortality. Materials and Methods: We retrospectively evaluated all consecutive COVID-19 patients admitted to the emergency department of nine Italian Hospitals from 1 March to 30 April 2020.The prevalence and the type of pre-existing AF have been collected. The correlation between the history and type of AF and the development of severe ARDS and in-hospital mortality has been evaluated. Results: In total, 467 patients (66.88 ± 14.55 years; 63% males) with COVID-19 were included in the present study. The history of AF was noticed in 122 cases (26.1%), of which 12 (2.6%) with paroxysmal, 57 (12.2%) with persistent and 53 (11.3%) with permanent AF. Among our study population, COVID-19 patients with AF history were older compared to those without AF history (71.25 ± 12.39 vs. 65.34 ± 14.95 years; p < 0.001); however, they did not show a statistically significant difference in cardiovascular comorbidities or treatments. Pre-existing AF resulted in being independently associated with an increased risk of developing severe ARDS during the hospitalization; in contrast, it did not increase the risk of in-hospital mortality. Among patients with AF history, no significant differences were detected in severe ARDS and in-hospital mortality between patients with permanent and non-permanent AF history. Conclusions: Pre-existing AF is a frequent among COVID-19 patients admitted to hospital, accounting up to 25% of cases. It is independently associated with an increased risk of severe ARDS in hospitalized COVID-19 patients; in contrast, it did not affect the risk of death. The type of pre-existing AF (permanent or non-permanent) did not impact ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/35334575; info:eu-repo/semantics/altIdentifier/wos/WOS:000774119700001; volume:58; issue:3; firstpage:399; lastpage:409; numberofpages:11; journal:MEDICINA; https://hdl.handle.net/11570/3247477; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85126556064 |
| DOI: | 10.3390/medicina58030399 |
| الاتاحة: | https://hdl.handle.net/11570/3247477 https://doi.org/10.3390/medicina58030399 |
| رقم الانضمام: | edsbas.6E2BA051 |
| قاعدة البيانات: | BASE |
| DOI: | 10.3390/medicina58030399 |
|---|